ADMA - ADMA Biologics - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

ADMA is currently covered by 4 analysts with an average potential upside of $4.17 (122.01%) backed by displayed 10 price targets and 36 ratings.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 26.9% with an average time for these price targets to be met of 253.86 days.

Highest price target for ADMA is 4, Lowest price target is 1, average price target is 2.5.

Most recent stock forecast was given by ELLIOT WILBUR from RAYMOND JAMES on 10-Aug-2023. First documented stock forecast 02-Dec-2013.

Currently, out of the existing stock ratings of ADMA - 18 which are a Buy (100%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

6

$2.45 (69.01%)

5

1 months 11 days ago

0/8 (0%)

$3.74 (199.68%)

Buy

5

$1.45 (40.85%)

4.5

1 months 11 days ago

4/5 (80%)

$1 (33.84%)

211

Buy

6

$2.45 (69.01%)

4.5

1 months 11 days ago

1/2 (50%)

$2.4 (130.32%)

642

Buy

5

$1.45 (40.85%)

10

11 months 8 days ago

0/4 (0%)

$4.37 (146.09%)

Buy

4

$0.45 (12.68%)

14

2 years 10 months 15 days ago

1/3 (33.33%)

$6.93 (191.15%)

917

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ADMA (ADMA Biologics) average time for price targets to be met?

On average it took 253.86 days on average for the stock forecasts to be realized with a an average price target met ratio 26.9

Which analyst has the current highest performing score on ADMA (ADMA Biologics) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the current lower performing score on ADMA (ADMA Biologics) with a proven track record?

KRISTEN KLUSKA

Which analyst has the most public recommendations on ADMA (ADMA Biologics)?

Raghuram Selvaraju works at HC WAINWRIGHT and has 12 price targets and 12 ratings on ADMA

Which analyst is the currently most bullish on ADMA (ADMA Biologics)?

Kristen Kluska with highest potential upside - $2.45

Which analyst is the currently most reserved on ADMA (ADMA Biologics)?

Jason Kolbert with lowest potential downside - $0.42

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart